Unique ID issued by UMIN | UMIN000035911 |
---|---|
Receipt number | R000040908 |
Scientific Title | Japan-Multidomain Intervention Trial for Prevention of Dementia in Older Adults with Diabetes. |
Date of disclosure of the study information | 2019/02/19 |
Last modified on | 2022/07/12 05:17:02 |
Japan-Multidomain Intervention Trial for Prevention of Dementia in Older Adults with Diabetes.
J-MIND-Diabetes study
Japan-Multidomain Intervention Trial for Prevention of Dementia in Older Adults with Diabetes.
J-MIND-Diabetes study
Japan |
Type 2 diabetes mellitus with mild cognitive impairment
Geriatrics |
Others
YES
The aim of this study is to identify wether multidomain intervention could prevent the progression of cognitive decline in older adults with type 2 diabetes mellitus classified into in category 2 according to the JGS/JDS Clinical Practice Guideline for the Treatment of Diabetes in the Elderly 2017.
Efficacy
Confirmatory
Pragmatic
Not applicable
Change in composite score of cognitive function from baseline to 18-month follow-up.
1) Change in composite score of cognitive function from baseline to 6-month follow-up.
2) Change in scores of each cognitive function from baseline to 6/18-month follow-up.
3) Change in Barthel Index and Lawton Index from baseleine to 6/18-month follow-up.
4) Change in status of frailty and sarcopenia from baseline to 6/18-month follow-up.
5) Change in the number of medications.
6) Cost-effectiveness.
7) Change in each result of comprehensive geriatric assement from baseline to 6/18-month follow-up.
8) Change in laboratory and urinary markers from baseline to 6/18-month follow-up.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is considered as a block.
YES
Central registration
2
Treatment
Behavior,custom |
Multidomain intervention including vascular risk factor management, exercise, diet and social engagement. Diabetes, hypertension, and dyslipidemia are treated according to their guidelines in Japan. Traning sessions are conducted. Nutritional advice is based on dietary guideline established by the JGD/JGS. For social engagement, going out is recommended. Subjects are requested to use a diary to record their diet, physical and social activity.
Usual care.
Text about prevention for dementia.
70 | years-old | <= |
85 | years-old | >= |
Male and Female
Subjects who
1) are diagnosed with type 2 diabetes mellitus
2) aged 70-85 at the time of enrollment
3) have no or slight impairment of basic acitivities of daily living (Barthel Index >= 80)
4) have cognitive impairment (MoCA-J < 26)
5) have MMSE score of 21-30
6) are outpatients or who have stable clinical corse for more than 4 weeks after their latest hospitalization or institutionalization and who have no need to change the medical examination classification during monitoring period.
7) are accompanied by a co-participant (study partner). The study partner must be physically and mentally healthy, contact the patient about once a week, and know how the patient lives. Preferably, the study partner should be able to make many visits together with the patient during the monitoring period.
8) have provided a written informed consent by subjects or their study partners.
1) Metabolic control is extremely poor (fasting plasma glucose level over 250 mg/dl; or urinay ketone bodies moderately positive above.
2) New hemorrahaging in the ocular fundus caused by proliferative retinopathy.
3) Renal failure.
4) Ischemic heart disease and cardiopulmonary disorders.
5) Presence of bone or joint disease.
6) Acute infectious disease.
7) Diabetes gangrene.
8) Severe autonomic neuropathy.
9) Parkinson's disease, apoplexy, Huntington's disease, normal pressure hydrocephalus, brain tumors, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, aphasia, epilepsy, subdural hematoma, encephalitis/meningitis, multiple sclerosis, or decreased cognitive function due to head injury.
10) Any local lesion such as cerebral infarction(s) detected by CT or MRI before enrollment that can greatly affect the cognitive function
11) History of major depression, bipolar disorder, schizophrenia, or alcohol/drug abuse; current serious or unstable disease
12) Patients unsuitable for treatment due to vitamin B1/B12 and/or folate deficiency, syphilis, or thyroid dysfunction
13) Patients deemed ineligible for enrollment by the responsible researcher or co-researcher at each institution
300
1st name | |
Middle name | |
Last name | Takashi Sakurai |
National Center for Geriatrics and Gerontology
Center for Comprehensive Care and Research on Memory Disorders
7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan
0562-46-2311
tsakurai@ncgg.go.jp
1st name | |
Middle name | |
Last name | Takashi Sakurai |
National Center for Geriatrics and Gerontology
Center for Comprehensive Care and Research on Memory Disorders
7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan
0562-46-2311
https://www.j-mind-diabetes.jp
j-mind@ncgg.go.jp
National Center for Geriatrics and Gerontology
Japan Agency for Medical Research and Development (AMED)
Japanese Governmental office
Japan
National Center for Geriatrics and Gerontology and 16 institusions in Japan
National Center for Geriatrics and Gerontology
NO
国立研究開発法人国立長寿医療研究センターと全国16施設
2019 | Year | 02 | Month | 19 | Day |
Unpublished
Completed
2018 | Year | 12 | Month | 27 | Day |
2018 | Year | 08 | Month | 02 | Day |
2019 | Year | 02 | Month | 20 | Day |
2022 | Year | 03 | Month | 31 | Day |
2019 | Year | 02 | Month | 18 | Day |
2022 | Year | 07 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040908